Skip to main content
. 2018 Jun 28;4:312–325. doi: 10.1016/j.isci.2018.05.021

Figure 5.

Figure 5

Expression Pattern of Viral Mimicry Genes in PD-L1IND and PD-L1CON Cell Lines and Patients with Melanoma

(A) Mean-centered heatmap of the expression level (log2 FPKMs) of 30 viral mimicry and immune-system-related genes in PD-L1IND and PD-L1CON cell lines.

(B) Heatmap of the expression level (scaled Z score) of the same set of 30 genes in TCGA skin cutaneous melanoma data stratified by TIL−/PD-L1− (group 1, representative of inducible in patient group) or TIL−/PD-L1+ (group 2, representative of constitutive in patient group). In both (A) and (B), significantly differentially expressed genes are indicated with an asterisk (*) and the gene names in a box are DNMTi-responsive genes (i.e., previously shown to be silenced and re-expressed upon DNMTi treatment in cancer).

(C–G) Gene expression of five of the nine selected ERV genes as measured by RT-qPCR. There is a higher expression of five ERV genes (MLTA10, MER21C, MLT1C627, MER4D, MER57B1) in the PD-L1CON cell lines compared with the PD-L1IND group. Error bars represent SE of two technical replicates.

See also Tables S6 and S7.